Back to Trials
NCT01205815Recruiting

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Vanderbilt-Ingram Cancer Center

Start Date

6/3/2010

Completion Date

6/1/2027

Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion criteria * Pathologically-proven diagnosis of melanoma. * Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible. Exclusion criteria * Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol. * Any patient unable or unwilling to provide consent.

Interventions

OTHER

Tissue and blood collection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Melanoma

Locations

Vanderbitl-Ingram Cancer Center

Nashville, Tennessee

United States